Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A muscle atrophy and drug technology, applied in the field of medicine, to achieve the effect of improving self-immunity and good curative effect
Inactive Publication Date: 2015-07-01
吴旭
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0002] Clinically, due to the lack of exact understanding of the etiology and pathogenesis of muscle atrophy, there is no eff
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Example Embodiment
[0008] Example 1, a medicine for the treatment of muscle atrophy, the material is composed of 15 parts by weight: Angelica sinensis 15 parts, Panax notoginseng 15 parts, Bupleurum 10 parts, Chinese wolfberry 12.5 parts, Antlers 9 parts, Passepartout 13 parts, fine 7 parts of Xin, 9 parts of dried tangerine peel, 12.5 parts of Salvia miltiorrhiza, and 14 parts of Achyranthes bidentata; the medicine is prepared into granules, capsules or decoctions according to conventional preparation techniques.
Example Embodiment
[0009] Example 2, a medicine for treating muscle atrophy, the materials are composed of 20 parts by weight: Angelica sinensis 20 parts, Panax notoginseng 20 parts, Bupleurum 12 parts, Lycium barbarum 15 parts, Antlers 12 parts, Passepartout 15 parts, Fine 9 parts of Xin, 10 parts of dried tangerine peel, 15 parts of Salvia miltiorrhiza, and 18 parts of Achyranthes bidentata; the medicine is prepared into granules, capsules or decoctions according to conventional preparation techniques.
Example Embodiment
[0010] Example 3, a medicine for the treatment of muscle atrophy, the material is composed of: 20 parts by weight of Angelica sinensis, 20 parts of Panax notoginseng, 12 parts of Bupleurum, 15 parts of Chinese wolfberry, 12 parts of antlers, 15 parts of Passepartout, thin 9 parts of Xin, 10 parts of dried tangerine peel, 15 parts of Salvia miltiorrhiza, and 18 parts of Achyranthes bidentata; the medicine is prepared into granules, capsules or decoctions according to conventional preparation techniques.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the technical field of medicine, and particularly relates to a drug for treating muscular atrophy. The drug is composed of the components in parts by weight: 10-20 parts of angelica sinensis, 10-20 parts of pseudo-ginseng, 8-12 parts of radix bupleuri, 10-15 parts of medlar, 6-12 parts of antler, 11-15 parts of beautiful sweetgum fruit, 5-9 parts of asarum sieboldii, 8-10 parts of pericarpium citri reticulatae, 10-15 parts of radix salviae miltiorrhizae, and 10-18 parts of radix cyathulae. The invention aims to provide the drug for treating muscular atrophy, wherein the drug is good in curative effect and improves the human body immunity.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating muscle atrophy. Background technique [0002] Clinically, because there is no definite understanding of the etiology and pathogenesis of muscular atrophy, there is no effective therapy and patent medicine in Chinese and Western medicine that can radically cure or prevent the development of this disease. Contents of the invention [0003] The purpose of the present invention is to provide a medicine for treating muscular atrophy with good curative effect and improving human body's self-immunity. [0004] The technical scheme adopted in the present invention is a medicine for treating muscle atrophy, and the materials are composed by weight: 10-20 parts of Angelica sinensis, 10-20 parts of Radix Notoginseng, 8-12 parts of Bupleuri, 10-15 parts of Lycium barbarum, 6-12 parts of antlers, 11-15 parts of Passepartout, 5-9 parts of Asarum, 8-10 parts of tange...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more